Incyte (INCY) Total Non-Current Liabilities (2013 - 2026)
Incyte (INCY) posted Total Non-Current Liabilities of $1.4 billion for Q2 2026, down 4.5% from $1.47 billion a year earlier and down 11.7% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Incyte's Total Non-Current Liabilities came in at $1.63 billion, down 11.1% from FY2024.
- Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
- In prior years, Incyte's Total Non-Current Liabilities was $1.83 billion in FY2024 (+28.9%), $1.42 billion in FY2023 (+10.3%), $1.29 billion in FY2022 (+34.5%) and $956.35 million in FY2021 (+32.4%).
- The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q3 2023.
- On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last five quarters, with growth averaging 4.4% over the last eight quarters.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q1 2022, with growth of 38.9%; the weakest was Q1 2026, with a decline of 16.6%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $1.59 billion (Q1 2026), $1.63 billion (Q4 2025) and $1.51 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Incyte | 24.39 Bn | 9.33 Bn | 1.57 Bn | 1.40 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.40 Bn |
| Mar 31, 2026 | 1.59 Bn |
| Dec 31, 2025 | 1.63 Bn |
| Sep 30, 2025 | 1.51 Bn |
| Jun 30, 2025 | 1.47 Bn |
| Mar 31, 2025 | 1.91 Bn |
| Dec 31, 2024 | 1.83 Bn |
| Sep 30, 2024 | 1.67 Bn |
| Jun 30, 2024 | 1.51 Bn |
| Mar 31, 2024 | 1.58 Bn |
| Dec 31, 2023 | 1.42 Bn |
| Sep 30, 2023 | 1.29 Bn |
| Jun 30, 2023 | 1.29 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.29 Bn |
| Sep 30, 2022 | 1.11 Bn |
| Jun 30, 2022 | 1.03 Bn |
| Mar 31, 2022 | 987.02 Mn |
| Dec 31, 2021 | 956.35 Mn |
| Sep 30, 2021 | 836.39 Mn |
API Access
Incyte Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();